Patents Assigned to Map IP Holding Limited
  • Prenatal screening
    Patent number: 10393729
    Abstract: The present invention relates to a method for screening maternal urine samples for changes in the pattern of mass spectral fingerprinting which have been found to be characteristic of fetal aneuploidies such as Down's Syndrome and have application for the 5 screening of other fetal abnormalities and disorders of pregnancy including gestational trophoblastic diseases.
    Type: Grant
    Filed: March 20, 2014
    Date of Patent: August 27, 2019
    Assignee: Map IP Holding Limited
    Inventors: Raymond Kruse Iles, Stephen Andrew Butler
  • Method for detecting abnormalities in hemoglobin
    Patent number: 10359431
    Abstract: The method describes rapid screening of whole blood samples, pin prick and blood spot cards, subjected to MALDI-ToF Mass spectrometry. The spectra is generated and compared to those from normal healthy controls. Characteristic spectra are indicative of the presence of a hemoglobinopathy and the method can be used to screen/diagnose all sickle cell diseases, alpha and beta Thalassemias.
    Type: Grant
    Filed: August 27, 2015
    Date of Patent: July 23, 2019
    Assignee: Map IP Holding Limited
    Inventors: Raymond Kruse Iles, Jason Kruse Iles, Thomas Abban, Suzanne Margaret Elizabeth Docherty, Mahmoud Naase
  • Rapid screening and evaluation of diabetes and prediabetes by glycated hemoglobin mass spectrometry
    Patent number: 10161941
    Abstract: The method describes rapid screening of whole blood samples, pin prick and blood spot cards, subjected to MALDI-ToF Mass spectrometry. The spectra is generated and compared to those from normal healthy controls. Characteristic spectra are indicative of the presence of a hemoglobinopathy and the method can be used to screen/diagnose all sickle cell diseases, alpha and beta Thalassemias.
    Type: Grant
    Filed: August 27, 2015
    Date of Patent: December 25, 2018
    Assignee: MAP IP Holding Limited
    Inventor: Raymond Kruse Iles
  • Methods Of Detecting Ectopic Pregnancy
    Publication number: 20170242023
    Abstract: A method for determining the likelihood of an ectopic pregnancy and spontaneous miscarriage is described, by measuring the levels of markers, especially hCG and CA-125 which have been found to be characteristic of these conditions. Preferably measuring these biomarker levels at earliest possible presentation of patients with general clinical symptoms and applying cut-off values described determines the likelihood of an ectopic pregnancy and spontaneous miscarriage.
    Type: Application
    Filed: July 2, 2014
    Publication date: August 24, 2017
    Applicant: Map IP Holding Limited
    Inventors: Raymond Kruse Iles, Stephen Andrew Butler